Miso Kim
Seoul National University(KR)Yonsei University(KR)Seoul National University Hospital(KR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Immune Cell Function and Interaction
Most-Cited Works
- → Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer(2019)100 cited
- → Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines(2020)95 cited
- → Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation(2012)71 cited
- → Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib(2018)65 cited
- → Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial(2020)55 cited
- → Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations(2019)39 cited